Unorganized Prostate-specific Antigen–based Screening for Prostate Cancer: More Harm than Benefit. When Will We Finally Start to Implement Guidelines and Risk Assessment Tools in Clinical Practice?

2015 ◽  
Vol 68 (3) ◽  
pp. 363-364 ◽  
Author(s):  
Monique J. Roobol
Keyword(s):  
Prostate Cancer ◽  
Risk Assessment ◽  
Clinical Practice ◽  
Prostate Specific Antigen ◽  
Specific Antigen ◽  
Assessment Tools ◽  
Risk Assessment Tools

scholarly journals The Benefits of Risk Assessment Tools for Prostate Cancer

2012 ◽  
Vol 61 (4) ◽  
pp. 662-663 ◽  
Author(s):  
Ian M. Thompson ◽  
Donna P. Ankerst
Keyword(s):  
Prostate Cancer ◽  
Risk Assessment ◽  
Assessment Tools ◽  
Risk Assessment Tools

Cumulative Prostate Cancer Risk Assessment with the Aid of the Free-to-Total Prostate Specific Antigen Ratio

2004 ◽  
Vol 45 (2) ◽  
pp. 160-165 ◽  
Author(s):  
Gunnar Aus ◽  
Charlotte Becker ◽  
Stefan Franzén ◽  
Hans Lilja ◽  
Pär Lodding ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Risk Assessment ◽  
Cancer Risk ◽  
Prostate Specific Antigen ◽  
Specific Antigen ◽  
Prostate Cancer Risk ◽  
Cancer Risk Assessment ◽  
Total Prostate Specific Antigen

Comparative analysis of three risk assessment tools in Australian patients with prostate cancer

2011 ◽  
Vol 108 ◽  
pp. 51-56 ◽  
Author(s):  
David J. Tamblyn ◽  
Samarth Chopra ◽  
Changhong Yu ◽  
Michael W. Kattan ◽  
Carole Pinnock ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Risk Assessment ◽  
Comparative Analysis ◽  
Assessment Tools ◽  
Risk Assessment Tools

Effective Use of Diabetes Risk Assessment Tools in Clinical Practice: Findings from a Literature Review

2012 ◽  
Vol 36 (5) ◽  
pp. S74-S75
Author(s):  
Maylene Fong ◽  
Ann F. Sarte ◽  
Kitty Yung ◽  
Laura Ng ◽  
Sharon Koehn ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Clinical Practice ◽  
Literature Review ◽  
Diabetes Risk ◽  
Assessment Tools ◽  
Risk Assessment Tools ◽  
Effective Use

scholarly journals Osteoporosis Canada 2010 Guidelines for the Assessment of Fracture Risk

2011 ◽  
Vol 62 (4) ◽  
pp. 243-250 ◽  
Author(s):  
◽  
Brian Lentle ◽  
Angela M. Cheung ◽  
David A. Hanley ◽  
William D. Leslie ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Clinical Practice ◽  
Fracture Risk ◽  
Fragility Fractures ◽  
Clinical Impact ◽  
Assessment Tools ◽  
Management Approach ◽  
Concerted Effort ◽  
Risk Assessment Tools ◽  
Fracture Risk Prediction

Osteoporosis Canada's 2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada focus on the clinical impact of fragility fractures, and on the assessment and management of women and men at high risk for fragility fracture. These guidelines now integrate a 10-year absolute fracture risk prediction into an overall management approach by using validated risk assessment tools. There currently is a large gap between optimal practices and those that are now being provided to Canadians with osteoporosis. These guidelines are part of a concerted effort to close this gap. Key changes from the 2002 guidelines of interest and relevance to radiologists are highlighted in this report.

scholarly journals Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

BMJ ◽  
2018 ◽  
pp. k3581 ◽  
Author(s):  
Kari A O Tikkinen ◽  
Philipp Dahm ◽  
Lyubov Lytvyn ◽  
Anja F Heen ◽  
Robin W M Vernooij ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Practice ◽  
Cancer Screening ◽  
Prostate Specific Antigen ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Prostate Cancer Screening ◽  
Specific Antigen ◽  
Psa Test
Sign in / Sign up

Export Citation Format

Share Document